199 related articles for article (PubMed ID: 36344947)
41. Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p.
Liu M; Jia J; Wang X; Liu Y; Wang C; Fan R
Cancer Biol Ther; 2018 May; 19(5):391-399. PubMed ID: 29336659
[TBL] [Abstract][Full Text] [Related]
42. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
Feng LL; Shen FR; Zhou JH; Chen YG
Gene; 2019 May; 696():105-112. PubMed ID: 30738960
[TBL] [Abstract][Full Text] [Related]
43. The ceRNA Mechanism of lncRNA MEG3/miR-21-5p/SPRY2 in Cell Proliferation and Apoptosis in Bladder Cancer.
Hong Y; Li Z; Su Y; Pu H; Zhang X
Crit Rev Eukaryot Gene Expr; 2024; 34(1):55-68. PubMed ID: 37824392
[TBL] [Abstract][Full Text] [Related]
44. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
45. HNRNPA2B1-mediated m
Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L
J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993
[TBL] [Abstract][Full Text] [Related]
46. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
Wang DY; Li N; Cui YL
Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
[TBL] [Abstract][Full Text] [Related]
47. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
Yang F; Guo L; Cao Y; Li S; Li J; Liu M
Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
[TBL] [Abstract][Full Text] [Related]
49. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
50. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
[TBL] [Abstract][Full Text] [Related]
51. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
Zhang LL; Hu D; Zou LH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
[TBL] [Abstract][Full Text] [Related]
52. LncRNA MEG3 inhibits the proliferation and migration abilities of colorectal cancer cells by competitively suppressing MiR-31 and reducing the binding of MiR-31 to target gene SFRP1.
Li Z; Zhao Z; Zhang G; Liu Y; Zheng S
Aging (Albany NY); 2023 Dec; 16(3):2061-2076. PubMed ID: 38309281
[TBL] [Abstract][Full Text] [Related]
53. LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205.
Yang W; Hong L; Xu X; Wang Q; Huang J; Jiang L
Tumour Biol; 2017 Jul; 39(7):1010428317711315. PubMed ID: 28671039
[TBL] [Abstract][Full Text] [Related]
54. LncRNA MEG3 inhibits proliferation and promotes apoptosis of synovial cells in rats with knee osteoarthritis by regulating PTEN.
Han K; Wang FR; Yu MQ; Xu B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5242-5248. PubMed ID: 32495857
[TBL] [Abstract][Full Text] [Related]
55. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
56. Effect of miR-301a/PTEN pathway on the proliferation and apoptosis of cervical cancer.
Peng LN; Shi WT; Feng HR; Wei CY; Yin QN
Innate Immun; 2019 May; 25(4):217-223. PubMed ID: 30943822
[TBL] [Abstract][Full Text] [Related]
57. Long Noncoding RNA MEG3 Suppresses Glioma Cell Proliferation, Migration, and Invasion by Acting as a Competing Endogenous RNA of miR-19a.
Qin N; Tong GF; Sun LW; Xu XL
Oncol Res; 2017 Nov; 25(9):1471-1478. PubMed ID: 28276316
[TBL] [Abstract][Full Text] [Related]
58. MiR-142-5p promotes retinoblastoma cell proliferation, migration and invasion by targeting PTEN.
Zhang Y; Zheng A
J Biochem; 2021 Oct; 170(2):195-202. PubMed ID: 34562091
[TBL] [Abstract][Full Text] [Related]
59. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
60. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.
Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H
J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]